Respiratory Syncytial Virus News and Research

RSS

Do we simply not care about old people?

The covid-19 pandemic would be a wake-up call for America, advocates for the elderly predicted: incontrovertible proof that the nation wasn't doing enough to care for vulnerable older adults.

9 Feb 2024

Gut microbiome may hold key to fighting common respiratory viruses

The composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, according to researchers from the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

30 Jan 2024

Impact of nirsevimab immunization on pediatric RSV-related hospitalizations in Luxembourg

Respiratory syncytial virus (RSV) is one of the main reasons leading to hospitalization among young children worldwide and each year, an estimated 101,000 children below the age of 5 years die due to RSV infections.

30 Jan 2024

‘Emergency’ or not, covid is still killing people. Here’s what doctors advise to stay safe.

With around 20,000 people dying of covid in the United States since the start of October, and tens of thousands more abroad, the covid pandemic clearly isn't over.

18 Jan 2024

Pandemic shifts: Ontario children's hospital visits and admissions down during COVID-19

Despite major disruptions to health care systems during the COVID-19 pandemic, there was no significant increase in preventable conditions or deaths in children according to a large study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221726.

16 Jan 2024

Study: Respiratory syncytial virus directly infects nerve cells and causes inflammation

Respiratory syncytial virus (RSV), a common infection in children and senior adults, can also infect nerve cells and trigger inflammation leading to nerve damage, according to a new Tulane University study.

10 Jan 2024

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy.

10 Jan 2024

There’s a new covid-19 variant and cases are ticking up. What do you need to know?

It's winter, that cozy season that brings crackling fireplaces, indoor gatherings — and a wave of respiratory illness.

8 Jan 2024

RSV vaccines would dramatically reduce disease burden if widely adopted like flu shots

Respiratory syncytial virus (RSV) vaccines recently approved for people 60 and older would dramatically reduce the disease's significant burden of illness and death in the United States if they were widely adopted like annual influenza vaccines, a new study has found.

2 Jan 2024

UVA biomedical engineer unveils hidden immune symphony during pregnancy

Sepideh Dolatshahi, an assistant professor of biomedical engineering at the University of Virginia, is spearheading an exploration of systems immunology in its crucial development phase - during pregnancy.

15 Dec 2023

Immunopeptidomics offer new hope in cancer research

In this new omg OMx podcast episode, Bruker's Kate Stumpo speaks to Nicola Ternette on the incredible world of immunopeptidomics - the implications they could have for research and how they help us understand the immune system better.

From Bruker Daltonics 13 Dec 2023

Leading public health groups urge high-risk patients to get flu shot

During National Influenza Vaccination Week (December 4-8, 2023), leading public health organizations are encouraging everyone to get a flu shot if they have not already done so.

4 Dec 2023

New 4-in-1 test can differentiate between swine flu, COVID-19, RSV, and influenza

The first case of a new strain of ‘swine flu’ has been detected in a human in the UK. The last swine flu pandemic killed 457 people in Britain alone. A leading testing expert says this strain looks to be very different but is urging Brits to take precautions.

4 Dec 2023

GOP presidential hopefuls use Trump’s covid record to court vaccine skeptics

Former President Donald Trump often seems proud to advertise his administration's record on speedily developing covid-19 vaccines.

29 Nov 2023

Children in daycare not significant spreaders of COVID-19, study shows

Parents who send their children to child care can breathe a little easier – research published in JAMA Network Open from experts at Michigan Medicine, the University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh shows that children in daycare were not significant spreaders of COVID-19.

27 Nov 2023

Surge in respiratory illnesses reported in China

Chinese authorities from the National Health Commission have reported an increase in incidence of respiratory diseases in China.

24 Nov 2023

Survey: Over a third of Americans worry about the "tripledemic" of respiratory illnesses

Over a third of American adults are worried that they or someone in their family will get the seasonal flu, Covid-19, or RSV (respiratory syncytial virus) in the next three months, according to a new health survey from the Annenberg Public Policy Center (APPC) of the University of Pennsylvania.

20 Nov 2023

Experts question Pfizer's failure to inform pregnant women of safety signal in GSK RSV vaccine trial

A debate has broken out over whether Pfizer should have told pregnant women taking part in its maternal respiratory syncytial virus (RSV) vaccine trial that a trial of a similar GSK vaccine was stopped over a safety signal around preterm birth, an investigation by The BMJ can reveal.

15 Nov 2023

Latest surveillance data shows a rise in antibiotic resistant infections and associated deaths

The latest national surveillance data, announced at the UK Health Security Agency (UKHSA) annual conference in Leeds today, shows that an estimated 58,224 people in England had an antibiotic resistant infection in 2022 - a rise of 4% since 2021 (55,792).